ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for ARTV

Stock NameArtiva Biotherapeutics, Inc. Common Stock
TickerARTV(USD) NASDAQ
TYPECommon Stock
CountryUSA

Show aggregate ARTV holdings

News associated with ARTV

Analysts Set Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) PT at $17.80
Shares of Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Get Free Report) have received a consensus rating of “Buy” from the four analysts that are presently covering the stock, Marketbeat.com reports. Four analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have issued a report on the stock in […] - 2025-08-15 02:24:51
Analysts Set Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Price Target at $17.80
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Get Free Report) has earned a consensus rating of “Buy” from the six analysts that are currently covering the firm, MarketBeat reports. Six investment analysts have rated the stock with a buy recommendation. The average 12 month target price among brokers that have covered the stock in the last year […] - 2025-07-21 02:14:53
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Receives $17.80 Consensus PT from Analysts
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Get Free Report) has been given a consensus recommendation of “Buy” by the six analysts that are currently covering the firm, MarketBeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average 12 month price objective among analysts that have updated their coverage on the stock […] - 2025-06-26 02:23:08
Deutsche Bank AG Takes Position in Artiva Biotherapeutics, Inc. (NASDAQ:ARTV)
Deutsche Bank AG purchased a new stake in shares of Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Free Report) during the fourth quarter, HoldingsChannel.com reports. The institutional investor purchased 21,423 shares of the company’s stock, valued at approximately $216,000. A number of other hedge funds and other institutional investors have also recently modified their holdings of the […] - 2025-06-03 05:26:48
Brokerages Set Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Price Target at $20.40
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Get Free Report) has earned a consensus recommendation of “Buy” from the six ratings firms that are covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12 month target price among brokers that have updated their coverage on the […] - 2025-05-07 02:19:06
Wedbush Reaffirms “Outperform” Rating for Artiva Biotherapeutics (NASDAQ:ARTV)
Artiva Biotherapeutics (NASDAQ:ARTV – Get Free Report)‘s stock had its “outperform” rating reaffirmed by equities researchers at Wedbush in a note issued to investors on Tuesday,Benzinga reports. They currently have a $18.00 price objective on the stock. Wedbush’s target price would indicate a potential upside of 394.51% from the company’s previous close. A number of […] - 2025-03-27 05:00:59
Needham & Company LLC Reiterates Buy Rating for Artiva Biotherapeutics (NASDAQ:ARTV)
Artiva Biotherapeutics (NASDAQ:ARTV – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at Needham & Company LLC in a report released on Tuesday,Benzinga reports. They presently have a $23.00 price target on the stock. Separately, HC Wainwright began coverage on shares of Artiva Biotherapeutics in a research report on Monday, December […] - 2025-03-27 04:01:01
Cantor Fitzgerald Lowers Artiva Biotherapeutics (NASDAQ:ARTV) Price Target to $20.00
Artiva Biotherapeutics (NASDAQ:ARTV – Free Report) had its price target cut by Cantor Fitzgerald from $23.00 to $20.00 in a research note published on Tuesday,Benzinga reports. They currently have an overweight rating on the stock. A number of other brokerages have also weighed in on ARTV. Needham & Company LLC reaffirmed a “buy” rating and […] - 2025-03-26 04:32:47
Brokerages Set Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) PT at $21.00
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Get Free Report) has earned an average recommendation of “Buy” from the six ratings firms that are presently covering the company, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have issued ratings on the stock in […] - 2025-02-21 04:18:45

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) ARTV holdings

DateNumber of ARTV Shares HeldBase Market Value of ARTV SharesLocal Market Value of ARTV SharesChange in ARTV Shares HeldChange in ARTV Base ValueCurrent Price per ARTV Share HeldPrevious Price per ARTV Share Held
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ARTV by Blackrock for IE00BYXG2H39

Show aggregate share trades of ARTV

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-06BUY1172.9303.000 2.993USD 350 3.30
2025-10-03BUY2732.9503.000 2.995USD 818 3.30
2025-10-02BUY392.9502.990 2.986USD 116 3.30
2025-09-30BUY782.8702.990 2.978USD 232 3.30
2025-09-26BUY782.9603.010 3.005USD 234 3.31
2025-09-25BUY783.0103.078 3.071USD 240 3.31
2025-09-18BUY392.3802.425 2.420USD 94 3.32
2025-09-17BUY1172.2802.550 2.523USD 295 3.32
2025-09-11SELL-392.6602.750 2.741USD -107 3.34 Profit of 24 on sale
2025-09-10BUY782.7002.845 2.831USD 221 3.35
2025-09-05SELL-393.6103.620 3.619USD -141 3.35 Loss of -10 on sale
2025-08-29SELL-1173.1503.301 3.286USD -384 3.36 Profit of 8 on sale
2025-08-27BUY783.2703.390 3.378USD 263 3.36
2025-08-26SELL-392.8402.915 2.907USD -113 3.36 Profit of 18 on sale
2025-08-25BUY392.8202.960 2.946USD 115 3.36
2025-08-20SELL-1562.7102.900 2.881USD -449 3.37 Profit of 77 on sale
2025-08-18BUY783.1003.239 3.225USD 252 3.38
2025-08-08SELL-782.7602.990 2.967USD -231 3.40 Profit of 34 on sale
2025-08-05BUY393.0803.090 3.089USD 120 3.41
2025-08-01SELL-1172.8302.950 2.938USD -344 3.42 Profit of 56 on sale
2025-07-30BUY1562.9803.150 3.133USD 489 3.43
2025-07-17SELL-782.5902.720 2.707USD -211 3.46 Profit of 59 on sale
2025-07-11SELL-3122.0402.070 2.067USD -645 3.50 Profit of 447 on sale
2025-07-07BUY1171.5801.640 1.634USD 191 3.56
2025-07-02BUY2,1451.5901.610 1.608USD 3,449 3.60
2025-06-25BUY781.6001.660 1.654USD 129 3.67
2025-06-11BUY781.9602.140 2.122USD 166 3.84
2025-06-10BUY782.0802.190 2.179USD 170 3.86
2025-06-04SELL-391.9701.990 1.988USD -78 3.93 Profit of 76 on sale
2025-04-23BUY392.4502.550 2.540USD 99 4.65
2025-04-10SELL-3121.8402.020 2.002USD -625 4.98 Profit of 930 on sale
2025-04-09SELL-391.9902.070 2.062USD -80 5.03 Profit of 116 on sale
2025-04-08SELL-391.9202.957 2.853USD -111 5.08 Profit of 87 on sale
2025-04-04SELL-1952.4402.530 2.521USD -492 5.15 Profit of 512 on sale
2025-04-01BUY1563.0003.200 3.180USD 496 5.22
2025-03-31SELL-1173.0003.310 3.279USD -384 5.26 Profit of 232 on sale
2025-03-14SELL-6245.1005.860 5.784USD -3,609 5.49 Loss of -186 on sale
2025-03-07SELL-785.3605.400 5.396USD -421 5.46 Profit of 5 on sale
2025-03-04SELL-394.3904.745 4.709USD -184 5.52 Profit of 32 on sale
2025-02-25BUY783.7603.900 3.886USD 303 5.76
2025-02-19SELL-394.0204.280 4.254USD -166 6.00 Profit of 68 on sale
2025-02-13BUY1174.0104.010 4.010USD 469 6.26
2025-02-12BUY393.6804.170 4.121USD 161 6.36
2025-02-11BUY1563.7204.055 4.021USD 627 6.47
2025-01-17BUY1566.5307.120 7.061USD 1,102 8.55
2025-01-16BUY1566.7807.055 7.027USD 1,096 8.80
2025-01-10SELL-789.35010.180 10.097USD -788 10.16 Profit of 5 on sale
2025-01-08SELL-15610.26011.550 11.421USD -1,782 9.97 Loss of -226 on sale
2025-01-02BUY1,3199.97010.300 10.267USD 13,542 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ARTV

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1937,2000141,95826.2%
2025-09-1831,303074,27642.1%
2025-09-1737,242064,42957.8%
2025-09-1610,186029,65734.3%
2025-09-1530,382063,67947.7%
2025-09-125,084022,19222.9%
2025-09-1117,226400122,66914.0%
2025-09-106,24062519,69931.7%
2025-09-0917,2002,07846,93036.7%
2025-09-0814,1813,27854,05126.2%
2025-09-0531,347079,18839.6%
2025-09-047,830023,51333.3%
2025-09-037,468017,35243.0%
2025-09-025,7042023,90023.9%
2025-08-297,166016,40143.7%
2025-08-287,529038,25319.7%
2025-08-2729,422076,03938.7%
2025-08-262,793027,43610.2%
2025-08-256,479013,09049.5%
2025-08-226,922036,92518.7%
2025-08-216,475015,07942.9%
2025-08-201,6764513,77712.2%
2025-08-1911,39020048,85523.3%
2025-08-1837,92175388,38642.9%
2025-08-1511,253026,89741.8%
2025-08-1410,259015,56865.9%
2025-08-1313,153024,06454.7%
2025-08-1224,571040,13361.2%
2025-08-118,938022,47839.8%
2025-08-0817,647044,43639.7%
2025-08-0710,898027,63839.4%
2025-08-0611,334055,33020.5%
2025-08-055,558017,73231.3%
2025-08-0430,999060,50851.2%
2025-08-0115,728050,12231.4%
2025-07-3115,047037,99839.6%
2025-07-3058,5510131,69944.5%
2025-07-2934,59680194,50236.6%
2025-07-2859,0265,885221,08326.7%
2025-07-2579,5730151,94352.4%
2025-07-2452,7740130,98540.3%
2025-07-2376,386390204,46237.4%
2025-07-2228,209054,88251.4%
2025-07-2134,5322068,25750.6%
2025-07-1842,7895,210211,56420.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy